TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24168257

Group type: EXPERIMENTAL
Intervention: Narlaprevir monotherapy for one week
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Narlaprevir/pegylated interferon-alpha-2b combination therapy for two weeks
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Narlaprevir retreatment
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Narlaprevir dosing
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Narlaprevir treatment
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Post-treatment follow-up
Number of subjects: 32
Study: 21172584

Group type: EXPERIMENTAL
Intervention: Duplex ultrasound (DUS) imaging
Number of subjects: 992

Group type: COMPARATOR
Intervention: Computed tomography (CT) imaging
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: Secondary interventions
Number of subjects: 992
Study: 19709109

Group type: COMPARATOR
Intervention: Bio‐Oss (control group)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Bio‐Oss and Bio‐Gide (test group)
Number of subjects: 14
Study: 17381934

Group type: EXPERIMENTAL
Intervention: Observed school meals
Number of subjects: 120

Group type: COMPARATOR
Intervention: Not observed school meals
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Prior 24 hours interviews
Number of subjects: 120

Group type: COMPARATOR
Intervention: Previous day interviews
Number of subjects: 120
Study: 15005645

Group type: EXPERIMENTAL
Intervention: 1500 mg Phase 2 twice daily with meals
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 11588409

Group type: EXPERIMENTAL
Intervention: Omapatrilat combined with hydrochlorothiazide
Number of subjects: 274

Group type: COMPARATOR
Intervention: Hydrochlorothiazide alone
Number of subjects: 274
Study: 9632325

Group type: EXPERIMENTAL
Intervention: Music walk
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control walk
Number of subjects: 19
Study: 8872666

Group type: EXPERIMENTAL
Intervention: Preferred limb (tennis playing arm)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Nonpreferred limb (non-tennis playing arm)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Acetylcholine infusion
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sodium nitroprusside infusion
Number of subjects: 8

Group type: COMPARATOR
Intervention: NG-mononmethyl-L-arginine infusion
Number of subjects: 8
Study: 2574084

Group type: EXPERIMENTAL
Intervention: Somatostatin (SMS) infusion (4 micrograms/min)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Somatostatin (SMS) infusion
Number of subjects: 6
Study: 1097203

Group type: EXPERIMENTAL
Intervention: Oral terbutaline (5 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oral ephedrine (25 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31730370

Group type: EXPERIMENTAL
Intervention: Augmented treatment (titrated risperidone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Basic treatment (placebo)
Number of subjects: 0
Study: 31533093

Group type: EXPERIMENTAL
Intervention: Intensive low-salt diet education
Number of subjects: 171

Group type: COMPARATOR
Intervention: Conventional education
Number of subjects: 171
Study: 28805135

Group type: EXPERIMENTAL
Intervention: Dabrafenib 150 mg twice daily plus trametinib 2 mg once daily (initially continuous dosing)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Intermittent dosing schedule (five‐week‐on and three‐week‐off)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Intermittent dosing schedule
Number of subjects: 2
Study: 25668654

Group type: EXPERIMENTAL
Intervention: High life satisfaction in individuals with schizophrenia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moderate-severe symptoms and severe functional deficits
Number of subjects: 0
Study: 23443947

Group type: EXPERIMENTAL
Intervention: 1% lidocaine with Tc-99m
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate with Tc-99m
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate-lidocaine with Tc-99m
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control (4% lidocaine cream and Tc-99m)
Number of subjects: 140
Study: 20953872

Group type: EXPERIMENTAL
Intervention: Laparoscopic sigmoidectomy
Number of subjects: 149

Group type: COMPARATOR
Intervention: Open sigmoidectomy
Number of subjects: 149
Study: 19906343

Group type: EXPERIMENTAL
Intervention: RLAI
Number of subjects: 37

Group type: COMPARATOR
Intervention: ORAL
Number of subjects: 37
Study: 16972829

Group type: EXPERIMENTAL
Intervention: hand-held video game (VG)
Number of subjects: 112

Group type: COMPARATOR
Intervention: parent presence (PP)
Number of subjects: 112

Group type: COMPARATOR
Intervention: 0.5 mg.kg‐1 oral midazolam (M)
Number of subjects: 112
Study: 15179204

Group type: EXPERIMENTAL
Intervention: Canalith repositioning maneuver with vibration
Number of subjects: 102

Group type: COMPARATOR
Intervention: Canalith repositioning maneuver without vibration
Number of subjects: 102
Study: 11419228

Group type: EXPERIMENTAL
Intervention: Current smokers who quit smoking by 28 weeks of pregnancy (n = 102)
Number of subjects: 897

Group type: COMPARATOR
Intervention: Continuing smokers
Number of subjects: 897

Group type: EXPERIMENTAL
Intervention: Higher levels of intrinsic motivation at baseline
Number of subjects: 897
Study: 9247476

Group type: EXPERIMENTAL
Intervention: 9 MU IFN three times a week for 6 months
Number of subjects: 272

Group type: COMPARATOR
Intervention: 6 MU IFN three times a week for 6 months
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: 9 MU IFN in patients with intermediate virus load (10(4)‐10(5) copies/mL)
Number of subjects: 272

Group type: COMPARATOR
Intervention: 6 MU IFN in patients with intermediate virus load (10(4)‐10(5) copies/mL)
Number of subjects: 272

Group type: COMPARATOR
Intervention: 6 MU IFN
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: 9 MU IFN
Number of subjects: 272
Study: 8495279

Group type: EXPERIMENTAL
Intervention: Deflazacort (DFZ)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Prednisone (PDN)
Number of subjects: 55
Study: 3651531

Group type: EXPERIMENTAL
Intervention: Lactate infusion
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Isoproterenol infusion
Number of subjects: 19

Group type: COMPARATOR
Intervention: 5% dextrose infusion
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Lactate and Isoproterenol infusions
Number of subjects: 19
Study: 31038440

Group type: EXPERIMENTAL
Intervention: Weekly ballet classes
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no dance classes)
Number of subjects: 19
Study: 28544009

Group type: EXPERIMENTAL
Intervention: Brief personality-targeted interventions delivered to high-risk youth during the first year of the trial.
Number of subjects: 3826

Group type: COMPARATOR
Intervention: Control group receiving no intervention above regular curriculum.
Number of subjects: 3826
Study: 26468478

Group type: EXPERIMENTAL
Intervention: Sour tea pill (500 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Captopril (12.5 mg twice daily)
Number of subjects: 20
Study: 24464572

Group type: EXPERIMENTAL
Intervention: Alcoholized group (0.06% BAC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (sober)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (learning effect observed)
Number of subjects: 20
Study: 21242557

Group type: EXPERIMENTAL
Intervention: EHR-based clinical decision support
Number of subjects: 5234

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5234

Group type: EXPERIMENTAL
Intervention: EHR-based clinical decision support for patients on low-dose aspirin
Number of subjects: 5234

Group type: COMPARATOR
Intervention: Usual care for patients on low-dose aspirin
Number of subjects: 5234
Study: 19101042

Group type: EXPERIMENTAL
Intervention: Bilateral choanal atresia patients
Number of subjects: 9

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 9
Study: 16922930

Group type: EXPERIMENTAL
Intervention: Intranasal immunization with E-GTF (n = 7)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control subjects (n = 12)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Tonsillar immunization (IT, n = 7)
Number of subjects: 26
Study: 12893996

Group type: EXPERIMENTAL
Intervention: Combination of relaxation and imagery delivered on two evenings
Number of subjects: 36
Study: 10630436

Group type: EXPERIMENTAL
Intervention: Casein hydrolysate formula
Number of subjects: 6

Group type: COMPARATOR
Intervention: Cow's milk‐based formula
Number of subjects: 6
Study: 9375877

Group type: EXPERIMENTAL
Intervention: Low dose amitriptyline (up to 30 mg nightly)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 8269183

Group type: EXPERIMENTAL
Intervention: Fish oil (12 g/d for 3 weeks)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fish oil (after olive oil)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Olive oil (12 g/d for 3 weeks)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 15

Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 15
Study: 2994988

Group type: EXPERIMENTAL
Intervention: Enalapril (5 to 20 mg twice‐daily) and Hydrochlorothiazide (50 to 100 mg/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Triple-drug therapy (Hydrochlorothiazide (50 to 100 mg/day), Timolol (10 to 30 mg twice‐daily), Hydralazine (50 to 150 mg twice‐daily)
Number of subjects: 18
Study: 31989291

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ice-pack application
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard care (Control group)
Number of subjects: 120
Study: 29493328

Group type: EXPERIMENTAL
Intervention: Ropivacaine infiltration of the lateral cutaneous femoral and subcostal nerve
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo infiltration
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Ropivacaine infiltration
Number of subjects: 162
Study: 27603903

Group type: EXPERIMENTAL
Intervention: Diazoxide (DZX) 4 mg/kg/d for 6 months
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Diazoxide (DZX)
Number of subjects: 35
Study: 24262433

Group type: EXPERIMENTAL
Intervention: 40 mmHg
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: 70 mmHg
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: 100 mmHg
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Pain scores
Number of subjects: 234
Study: 21835081

Group type: EXPERIMENTAL
Intervention: Multi-component programme delivered in school by teachers and items sent home for parents/children
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Eating main meal with parents 3-7 nights/week
Number of subjects: 311

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 311
Study: 20171357

Group type: EXPERIMENTAL
Intervention: IAN block administered with a peripheral nerve stimulator
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional IAN block with 2% lidocaine and 1:100,000 epinephrine
Number of subjects: 46
Study: 18598837

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin and hydrocortisone (CHC) 3 drops twice daily for 7 days
Number of subjects: 206

Group type: COMPARATOR
Intervention: NPH + AMX (neomycin/polymyxin b/hydrocortisone with systemic amoxicillin)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin and hydrocortisone (CHC)
Number of subjects: 206
Study: 15830198

Group type: EXPERIMENTAL
Intervention: Acri. Twin MIOL
Number of subjects: 30

Group type: COMPARATOR
Intervention: Array SA40 MIOL
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both MIOL
Number of subjects: 30
Study: 11940133

Group type: EXPERIMENTAL
Intervention: Zelen design intervention group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional randomized controlled trial
Number of subjects: 0
Study: 10355618

Group type: EXPERIMENTAL
Intervention: Proprietary liquid dentifrice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluoride toothpaste
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water (negative control)
Number of subjects: 0
Study: 8530574

Group type: EXPERIMENTAL
Intervention: Nafarelin (NAF; 400 micrograms, intranasal spray, twice daily)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Norethindrone (NOR 1/35; 0.035 mg, daily, for 3 of 4 weeks)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Combination of Nafarelin and Norethindrone
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 1742820

Group type: EXPERIMENTAL
Intervention: Clonidine (150 micrograms)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Epinephrine (200 micrograms)
Number of subjects: 60
Study: 7037351

Group type: EXPERIMENTAL
Intervention: Optisulin ‐depot CS (25% dissolved porcine Des‐Phe‐insulin/insulin and 75% crystalline porcine insulin)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Depot Insulin Hoechst CS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Insulin Leo Mixtard
Number of subjects: 20
Study: 31285653

Group type: EXPERIMENTAL
Intervention: Peyton's 4-step approach
Number of subjects: 16

Group type: COMPARATOR
Intervention: Traditional method
Number of subjects: 16
Study: 27372380

Group type: EXPERIMENTAL
Intervention: Perineural dexamethasone (8mg)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: IV dexamethasone (8mg)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Perineural dexamethasone
Number of subjects: 81
Study: 25925484

Group type: EXPERIMENTAL
Intervention: Digoxin therapy
Number of subjects: 0
Study: 24926544

Group type: EXPERIMENTAL
Intervention: Pemetrexed
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 23049590

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid (ICS) treatment for 6 weeks
Number of subjects: 148

Group type: COMPARATOR
Intervention: Untreated group (guideline‐based management)
Number of subjects: 148
Study: 19032569

Group type: EXPERIMENTAL
Intervention: Video calls
Number of subjects: 180

Group type: COMPARATOR
Intervention: Audio calls
Number of subjects: 180
Study: 18182872

Group type: EXPERIMENTAL
Intervention: Hand acupuncture therapy using New Seoam Press Pellets number 1 for 4 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham group using Adhesive tape for 4 weeks
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Cerebral blood flow test
Number of subjects: 22
Study: 16089103

Group type: EXPERIMENTAL
Intervention: Chemo-radiotherapy (cisplatin + etoposide + early concurrent thoracic radiotherapy)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Chemotherapy (cisplatin + etoposide)
Number of subjects: 72
Study: 11923793

Group type: EXPERIMENTAL
Intervention: Intercessory Prayer (IP) for 14 consecutive days starting the night before surgery
Number of subjects: 1802

Group type: COMPARATOR
Intervention: No Intercessory Prayer (IP)
Number of subjects: 1802

Group type: EXPERIMENTAL
Intervention: Informed they would receive additional IP and did so
Number of subjects: 1802
Study: 10617169

Group type: EXPERIMENTAL
Intervention: Paroxetine (40 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 8606523

Group type: COMPARATOR
Intervention: 80 mg propranolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 25 mg talinolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 50 mg talinolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 mg talinolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 400 mg talinolol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2291875

Group type: EXPERIMENTAL
Intervention: Medifoxamine 100 mg by i.v. infusion over 15 min
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Medifoxamine 500 mg by mouth fasting
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Oral Medifoxamine
Number of subjects: 12
Study: 7396472

Group type: EXPERIMENTAL
Intervention: 1 g of probenecid administered concomitantly with 2 g of cefoxitin intravenously
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1 g of probenecid administered 1 hour prior to 2 g of cefoxitin intravenously
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 2 g of probenecid administered with 2 g of cefoxitin intramuscularly
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1 g of probenecid administered before 2 g of cefoxitin intravenously
Number of subjects: 12
Study: 31478939

Group type: EXPERIMENTAL
Intervention: Mini-thoracoscopy
Number of subjects: 73

Group type: COMPARATOR
Intervention: Semirigid thoracoscopy
Number of subjects: 73
Study: 31757089

Group type: EXPERIMENTAL
Intervention: Vibration feedback
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (no feedback)
Number of subjects: 26
Study: 28922999

Group type: EXPERIMENTAL
Intervention: Adaptive auditory‐visuospatial dual n‐back training task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active or Passive WM composites
Number of subjects: 0
Study: 25830402

Group type: EXPERIMENTAL
Intervention: Splinted cemented restorations
Number of subjects: 44

Group type: COMPARATOR
Intervention: Nonsplinted cemented restorations
Number of subjects: 44
Study: 23314231

Group type: EXPERIMENTAL
Intervention: Subthreshold argon laser therapy
Number of subjects: 37

Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 37
Study: 21784084

Group type: EXPERIMENTAL
Intervention: Distance from laser head to skin at 10 cm
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Distance from laser head to skin at 15 cm
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Distance from laser head to skin at 20 cm
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Distance from laser head to skin at 30 cm
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Distance from laser head to skin (10-30 cm interval)
Number of subjects: 11
Study: 19563191

Group type: EXPERIMENTAL
Intervention: Injection at acupoint combined with warming needle therapy
Number of subjects: 197

Group type: COMPARATOR
Intervention: Electroacupuncture
Number of subjects: 197
Study: 17984151

Group type: EXPERIMENTAL
Intervention: Coaching intervention (10 weekly sessions, 15-30 minutes each over three months)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no coaching intervention)
Number of subjects: 12
Study: 14624393

Group type: EXPERIMENTAL
Intervention: Margarine with added plant sterols
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: PUFA margarine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Both types of margarine
Number of subjects: 42
Study: 11199374

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Procaine
Number of subjects: 40
Study: 9166032

Group type: EXPERIMENTAL
Intervention: 12% sucrose
Number of subjects: 19

Group type: COMPARATOR
Intervention: distilled water (placebo)
Number of subjects: 19
Study: 8260371

Group type: EXPERIMENTAL
Intervention: Recombinant interleukin 2 (rIL-2) 120 h continuous infusion at 18 x 10(6) iu m‐2 day followed by three injections of 5FU 600 mg m‐2 at weekly intervals
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Weekly 5FU (after initial treatment with rIL-2)
Number of subjects: 16
Study: 3978007

Group type: EXPERIMENTAL
Intervention: Fentanyl continuous i.v. infusion at 1.5 microgram kg‐1 min‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fentanyl continuous i.v. infusion at 0.5 microgram kg‐1 min‐1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 0
Study: 29350276

Group type: EXPERIMENTAL
Intervention: Swimming exercise
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no swimming exercise)
Number of subjects: 70
Study: 25730290

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTX‐A) - single dose of 10 units per kilogram body weight
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTX‐A)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 125
Study: 25436661

Group type: EXPERIMENTAL
Intervention: Protocol A (PPT insoles for 30 days, then silicone orthosis for toes for another 30 days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Protocol B (PPT insoles and silicone orthosis for 30 days, then only insoles for another 30 days)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both protocols
Number of subjects: 24
Study: 22591059

Group type: EXPERIMENTAL
Intervention: Step-up treatment strategy (antacid 4dd + placebo 1dd)
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Step-down treatment strategy (proton pump inhibitor 1dd + placebo 4dd)
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Step 3 (five pills/day, placebo and verum vice versa from step 1)
Number of subjects: 653

Group type: COMPARATOR
Intervention: Active medication vs. placebo
Number of subjects: 653

Group type: EXPERIMENTAL
Intervention: Intake fidelity errors
Number of subjects: 653
Study: 20732526

Group type: EXPERIMENTAL
Intervention: Awake group (thoracic epidural anesthesia and spontaneous ventilation)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (general anesthesia with one-lung ventilation)
Number of subjects: 50
Study: 18950330

Group type: COMPARATOR
Intervention: Intravenous fentanyl (2 mcg x kg(‐1)) and infraorbital nerve block with 0.5 ml preservative-free normal saline on each side
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Bilateral infraorbital nerve blocks with 0.5 ml on each side of 0.25% bupivacaine and 2 ml of preservative-free saline solution intravenously
Number of subjects: 46
Study: 16192766

Group type: EXPERIMENTAL
Intervention: Rapid crystalloid infusion (group 1)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Minimal maintenance rate crystalloid infusion (group 0)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Neonatal outcome
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Maternal side effects
Number of subjects: 112
Study: 12814476

Group type: EXPERIMENTAL
Intervention: FTY720 (0.25 to 3.5 mg)
Number of subjects: 24
Study: 10385641

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) treatment for 4 weeks
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) treatment for 2 years
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 25
Study: 8610601

Group type: EXPERIMENTAL
Intervention: Intravenous heparin
Number of subjects: 1735

Group type: COMPARATOR
Intervention: Control (no heparin)
Number of subjects: 1735
Study: 1802393

Group type: EXPERIMENTAL
Intervention: 10 mg NGT
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20